InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,304.72
(
0.70%
)
US TECH 100
18,318.00
(
0.95%
)
Dow Jones
39,069.59
(
0.01%
)
Brent Oil
81.97
(
0.00%
)
Bitcoin
69,101.68
(
0.83%
)
Post# of 2795
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

ghmm

Send PM Follow Ignore
Followers 50
Posts 6343
Boards Moderated 0
Alias Born 01/22/2006

ghmm

Re: DewDiligence post# 1926

Tuesday, 10/18/2016 11:20:34 AM

Tuesday, October 18, 2016 11:20:34 AM

Post# of 2795
At quick glance looks the same as september (I like the newer slide deck better than what they were using before)

The enrollment slide of it being changed from 200 to 230 bothered me so I went back to double check as I recalled initial enrollment being much lower

Here is the first change from 140 to 200
https://clinicaltrials.gov/archive/NCT01966419/2014_05_21/changes

I didn't recall that being done.

And then the second change on DSMB recommendation
https://clinicaltrials.gov/archive/NCT01966419/2016_01_14/changes
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up